Zolgensma Found Most Beneficial for Presymptomatic Infants with SMA
Administering Gene Therapy in First Six Weeks of Life Yields Improved Outcomes
Progress in SMA Research and Advocacy Celebrated at Hope on the Hill Event
Cure SMA’s annual gathering has raised over $2M since its inception in 2011